about
mTOR inhibitors in advanced renal cell carcinomaTargeting the insulin growth factor receptor 1Perioperative Therapy for Surgically Resectable Pancreatic AdenocarcinomaFamilial Pancreatic AdenocarcinomaEpidemiology and Inherited Predisposition for Sporadic Pancreatic AdenocarcinomaDoes my patient with a serum monoclonal spike have multiple myeloma?Targeting angiogenesis in gynecologic cancersImmune thrombocytopeniaManagement of patients with biochemical recurrence after local therapy for prostate cancerIbrutinib (PCI-32765) in chronic lymphocytic leukemiaCustomized targeted therapy in Hodgkin lymphoma: hype or hope?Chronic granulomatous diseaseThe role of adenosine signaling in sickle cell therapeuticsModulation of hepcidin as therapy for primary and secondary iron overload disorders: preclinical models and approachesMolecular Aspects of Head and Neck Cancer TherapyCell(s) of Origin of Langerhans Cell HistiocytosisEssential thrombocythemiaThe epidemiology of prostate cancer--with a focus on nonsteroidal anti-inflammatory drugsGastrointestinal stromal tumor: a clinical overviewCold agglutinin-mediated autoimmune hemolytic anemiaLaboratory evaluation of the antiphospholipid syndromeTcl1 as a model for lymphomagenesisTherapy-related myeloid leukemiaPeripheral T-cell non-Hodgkin's lymphomaFuture Directions in Improving Outcomes for Patients with Gastric and Esophageal Cancer.Novel Agents in the Treatment of Relapsed or Refractory Peripheral T-Cell Lymphoma.CD30+ Lymphoproliferative Disorders of the Skin.T-cell Prolymphocytic Leukemia.Adult T-cell Leukemia/Lymphoma: A Problem Abroad and at Home.Clinical Features and Current Optimal Management of Natural Killer/T-Cell Lymphoma.Angioimmunoblastic T-Cell Lymphoma.Management of Anaplastic Large Cell Lymphoma.Mantle Cell Lymphoma: Is It Time for a New Treatment Paradigm?Optimizing Outcomes in Primary Mediastinal B-cell Lymphoma.Management of Relapsed Diffuse Large B-cell Lymphoma.Diffuse Large B-Cell Lymphoma: Should Limited-Stage Patients Be Treated Differently?Chemoradiation in conservation therapy for esophageal cancer.Etiologic differences between seminoma and nonseminoma of the testis: a systematic review of epidemiologic studies.Integrative oncology: complementary therapies for cancer survivors.The management of synchronous bilateral Wilms tumor.
P1433
Q24612127-DA117DAB-55BC-47D4-8C21-CDF1107FB03FQ24633750-96ED4AC8-F5DD-456C-8E39-B3C1F84EF9B8Q26801411-F9FF4143-A269-4EED-B5EF-C27EF4815085Q26801415-0D3114FA-CF43-4A8F-B1C4-7F3D7E701D35Q26801418-89C3F302-DFC6-40CD-BCA8-C33D46D4AF84Q26821981-8C09444B-7943-4A34-B537-FE458ED66ACEQ26824766-9B5B7985-6D93-4D54-B7EF-EE02AA60B817Q26830918-98A4923C-8262-45C7-87F2-FF31B9654FC8Q26849220-8ACEC618-5F12-458B-8768-037F78706236Q26852328-A02827D1-8118-4C12-8831-0F20D50654A2Q27002554-DEB42200-F834-47D4-9848-A4F4B0C0FC78Q27009322-F57DA212-949A-486E-B854-4D1B3FB2A1C2Q27010098-0D31AA1D-40A0-43C5-8C2C-5DF895B9F549Q27027657-11DD1B8D-36C1-4281-AD29-225B61BD5176Q28082815-A39CC7D4-B944-4E9B-A422-4CEC6E92E78AQ28087231-E6664B00-1E30-4334-8507-68BF588846A2Q28165670-CD69A70C-3396-4FBE-A905-468F98AF12B6Q28199687-CECBC0B0-AE03-4889-BBD9-78490DE00DD8Q28236631-E5064C23-825F-4882-BBEC-C82055FEE1ACQ28262907-0FE577AC-C611-42AA-9F71-9349D50F50D2Q28265401-CE54354D-B999-4F09-851B-69220E7E6538Q28278345-B20DCA62-5745-4ACC-9000-D02F5416E851Q28284888-E8727ABC-4192-45E1-B7DF-C153D1613161Q28298860-E2156396-8FE5-44B7-90D5-2865E3B655B0Q30234476-FF260B65-3A06-4007-AAE4-B16ECCA8D9C4Q30235095-F1AA70AC-3275-46C5-8311-870ED37621E5Q30235097-63B4ED6A-A71D-47AC-B7B7-8D7E6012AC70Q30235099-74E9BB3F-0026-4F02-85BD-C63F090C709EQ30235100-3231CC67-3A30-4A32-AFBE-6D7BE82B5498Q30235101-22379587-7C80-4BE3-A102-79F09C7DE7CAQ30235102-5F651D0F-5DDC-4DD7-899A-AF369FDB2143Q30235103-C1CA7203-A541-434E-A84E-A33AF36095E9Q30240619-77F08B37-8F76-4E48-9F09-1B5E9AEC890AQ30240621-33874F21-B1E8-45C4-858C-E1A154FA6FE0Q30240622-56329A70-44AB-40BC-A332-B15E3DD8F92FQ30240625-8FB72895-5732-473D-A2E4-BE5F84A19BDDQ30307432-D013E80A-4789-416E-AB42-EE00525C54A0Q30318403-D531D0DE-5EB4-4A74-B887-271477014BE8Q30368695-620529F2-4A8B-43A0-A666-CF7DAF404610Q30423601-B2CB9819-7EFF-42ED-9BD1-D5105E7C27CF
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
vědecký časopis
@cs
wetenschappelijk tijdschrift van Elsevier
@nl
wissenschaftliche Fachzeitschrift
@de
مجلة
@ar
वैज्ञानिक पत्रिका
@hi
name
Hematology / Oncology Clinics of North America
@ast
Hematology / Oncology Clinics of North America
@da
Hematology / Oncology Clinics of North America
@en
Hematology / Oncology Clinics of North America
@es
Hematology / Oncology Clinics of North America
@fi
Hematology / Oncology Clinics of North America
@fr
Hematology / Oncology Clinics of North America
@it
Hematology / Oncology Clinics of North America
@nb
Hematology / Oncology Clinics of North America
@nl
Hematology / Oncology Clinics of North America
@nn
type
label
Hematology / Oncology Clinics of North America
@ast
Hematology / Oncology Clinics of North America
@da
Hematology / Oncology Clinics of North America
@en
Hematology / Oncology Clinics of North America
@es
Hematology / Oncology Clinics of North America
@fi
Hematology / Oncology Clinics of North America
@fr
Hematology / Oncology Clinics of North America
@it
Hematology / Oncology Clinics of North America
@nb
Hematology / Oncology Clinics of North America
@nl
Hematology / Oncology Clinics of North America
@nn
prefLabel
Hematology / Oncology Clinics of North America
@ast
Hematology / Oncology Clinics of North America
@da
Hematology / Oncology Clinics of North America
@en
Hematology / Oncology Clinics of North America
@es
Hematology / Oncology Clinics of North America
@fi
Hematology / Oncology Clinics of North America
@fr
Hematology / Oncology Clinics of North America
@it
Hematology / Oncology Clinics of North America
@nb
Hematology / Oncology Clinics of North America
@nl
Hematology / Oncology Clinics of North America
@nn
P3181
P1055
P1058
P1156
P123
P1250
P1277
P1476
Hematology / Oncology Clinics of North America
@en